
109 articles

US FDA approves Pfizer, Arvinas’ breast cancer drug on May 2, 2026, offering new hope and a significant advancement in o…

New research from May 1, 2026, shows cancer immunotherapy could cure autoimmune diseases, offering hope and shifting hea…

Global outbreak alerts issued for 19 countries on May 1, 2026, highlighting widespread health challenges and the need fo…

Pharco Pharmaceuticals’ Ravidasvir approved in Thailand for Hepatitis C treatment on April 30, 2026, a strategic healthc…

UHN researchers investigate new therapies as colon cancer rises among young patients, prompting urgent focus on advanced…

A new longevity trial is underway testing three FDA-approved drugs, potentially redefining healthy aging and disease pre…

Global infectious outbreaks have fundamentally reshaped cancer care, altering patient management, research, and infrastr…

The Brain-Gut Health Initiative backs AI-assisted diagnosis of psychiatric disorders, promising precise, timely care and…

A new computational protocol accelerates Chagas drug discovery, offering a significant leap in identifying new treatment…

The slow march of clinical biomarkers to become surrogate endpoints promises to accelerate drug development and patient…

CSPC Pharmaceutical’s SYH2059 KAT6 inhibitor receives FDA approval for clinical trials in the U.S., marking a significan…